Prediction of High Ovarian Response to Controlled Ovarian Hyperstimulation: Anti-Müllerian Hormone Versus Small Antral Follicle Count (2–6 mm)
Antral follicle count by transvaginal ultrasound is reflective of the actual primordial follicle pool
Quantitative Transvaginal Two- and Three-Dimensional Sonography of the Ovaries: Reproducibility of Antral Follicle Counts
The Use of Anti-Müllerian Hormone and Antral Follicle Count to Predict the Potential of Oocytes and Embryos
Intraobserver and Interobserver Reliability of Automated Antral Follicle Counts Made Using Three-Dimensional Ultrasound and SonoAVC
Correlations Between Antral Follicle Count and Ultrasonographic Ovarian Parameters and Clinical Variables and Outcomes in IVF Cycles
The Antral Follicle Count Predicts the Outcome of Pregnancy in a Controlled Ovarian Hyperstimulation/Intrauterine Insemination Program
Antral Follicle Counts Are Strongly Associated With Live-Birth Rates After Assisted Reproduction, With Superior Treatment Outcome in Women With Polycystic Ovaries
Technical and Performance Characteristics of Anti-Müllerian Hormone and Antral Follicle Count as Biomarkers of Ovarian Response.
Three-Dimensional Ultrasound Improves the Interobserver Reliability of Antral Follicle Counts and Facilitates Increased Clinical Work Flow
